Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms

Table 10 Main features of SAFE biopsy[6794] for significant fibrosis and cirrhosis in 2035 HCV cases

	Significant fibrosis	Cirrhosis
Sensitivity (%)	100	92.7
Specificity (%)	77	90.4
Accuracy (%)	90	93
AUROC	0.9	0.92
Saved biopsies (%)	47	82

SAFE: Sequential algorithms for fibrosis evaluation; AUROC: Area under the receiving operating characteristic curve.